Sunday, May 04, 2014 9:52:08 PM
$INO
DD Notes ~ http://www.ddnotesmaker.com/INO
##### recent news/filings ~ source: finance.yahoo.com
Mon, 21 Apr 2014 14:35:00 GMT ~ Inovio Pharmaceuticals (INO) Is Today's Dead Cat Bounce Stock
read full: http://www.thestreet.com/story/12675964/1/inovio-pharmaceuticals-ino-is-todays-dead-cat-bounce-stock.html?puc=yahoo&cm_ven=YAHOO
*********************************************************
Wed, 09 Apr 2014 16:06:20 GMT ~ I Hear The Shorts Knocking, But, I'm Staying Long On Inovio
read full: http://seekingalpha.com/article/2133403-i-hear-the-shorts-knocking-but-im-staying-long-on-inovio?source=yahoo
*********************************************************
Mon, 07 Apr 2014 13:30:00 GMT ~ 3 Stocks To Profit From The Cutting-Edge Vaccine Market
read full: http://finance.yahoo.com/news/biotech-market-could-quadruple-3-133000076.html
*********************************************************
Fri, 04 Apr 2014 15:50:00 GMT ~ Use Options For A Chance To Buy INO At A 42% Discount
read full: http://www.thestreet.com/story/12626953/1/use-options-for-a-chance-to-buy-ino-at-a-42-discount.html?puc=yahoo&cm_ven=YAHOO
*********************************************************
Tue, 01 Apr 2014 08:00:00 GMT ~ Inovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality
[PR Newswire] - BLUE BELL, Pa., April 1, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced the appointment of E.J. Brandreth as Vice President of Quality. He will be responsible for all quality and compliance functions for a company that is moving forward with numerous late and early stage clinical trials and scaling up manufacturing and other operational areas to support its broad pipeline of immunotherapies and DNA vaccines. He will report to Inovio's Chief Operating Officer Dr. Niranjan Sardesai. Prior to joining Inovio, Mr. Brandreth had a successful career transitioning start-up clinical biotech operations into successful commercial entities;
read full: http://finance.yahoo.com/news/inovio-pharmaceuticals-continues-building-senior-080000621.html
*********************************************************
##### chart ~ source: stockcharts.com
##### chart ~ source: eoddata.com
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/INO/company-info
Ticker: $INO
OTC Market Place: Not Available
CIK code: 0001055726
Company name: Inovio Pharmaceuticals, Inc.
Company website: http://www.inovio.com/
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001055726&owner=exclude&count=40
Latest filings: http://www.otcmarkets.com/stock/INO/filings
Latest financials: http://www.otcmarkets.com/stock/INO/financials
Latest news: http://www.otcmarkets.com/stock/INO/news - http://finance.yahoo.com/q/h?s=INO+Headlines
Major holdings: http://data.cnbc.com/quotes/INO/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=INO+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/INO.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=INO
RegSho: http://www.regsho.com/tools/symbol_stats.php?sym=INO&search=search
DTCC: http://search2.dtcc.com/?q=Inovio+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&q=Inovio+Pharmaceuticals%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results?term=Inovio+Pharmaceuticals%2C+Inc.&x=0&y=0
WHOIS: http://whois.domaintools.com/http://www.inovio.com/
Alexa: http://www.alexa.com/siteinfo/http://www.inovio.com/#
Corporate website internet archive: http://web.archive.org/web/*/http://www.inovio.com/
Short Sales: http://www.otcmarkets.com/stock/INO/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/INO/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/INO/research
Historical Prices: http://finance.yahoo.com/q/hp?s=INO+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=INO+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=INO+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=INO+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=INO+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=INO+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=INO
Balance Sheet: http://finance.yahoo.com/q/bs?s=INO
Cash Flow: http://finance.yahoo.com/q/cf?s=INO+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/INO
Bloomberg: http://www.bloomberg.com/quote/INO:US
Morningstar: http://quotes.morningstar.com/stock/s?t=INO
Bussinessweek: http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=INO
Barchart: http://www.barchart.com/quotes/stocks/INO
OTC Short Report: http://otcshortreport.com/index.php?index=INO
Investopedia: http://www.investopedia.com/markets/stocks/INO/?wa=0
http://www.pennystocktweets.com/stocks/profile/INO
##### last known share structure ~ source: otcmarkets.com
Market Value: $613,400,986 a/o May 02, 2014
Shares Outstanding: 239,609,760 a/o Mar 07, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
##### business description ~ source: otcmarkets.com
The achievements of stimulating the immune system through vaccination have been profound. INO?s synthetic vaccines are designed to treat as well as prevent illnesses, aiming to break the body?s tolerance of cancerous cells and protect against diverse while changing strains of infectious diseases. INO?s SynCon? vaccines are designed to provide universal cross-strain protection against known as well as newly emergent unmatched strains of pathogens such as influenza. These synthetic vaccines, in combination with Inovio's proprietary electroporation delivery, have been shown in humans to generate best-in-class immune responses with a favorable safety profile.Less >>
DD Notes ~ http://www.ddnotesmaker.com/INO
Recent INO News
- INOVIO Reports Inducement Grants Under Inducement Plan • PR Newswire (US) • 10/02/2024 08:15:00 PM
- INOVIO to Present at Upcoming Scientific Conferences • PR Newswire (US) • 10/01/2024 12:00:00 PM
- INOVIO to Present at Upcoming Scientific Conference • PR Newswire (US) • 09/17/2024 08:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/13/2024 10:22:02 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 10:06:54 AM
- INOVIO Reports Second Quarter 2024 Financial Results and Recent Business Highlights • PR Newswire (US) • 08/08/2024 08:05:00 PM
- INOVIO Reports Inducement Grant Under Inducement Plan • PR Newswire (US) • 08/01/2024 08:05:00 PM
- Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107 • PR Newswire (US) • 07/25/2024 08:05:00 PM
- INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024 • PR Newswire (US) • 07/25/2024 12:00:00 PM
- INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway • PR Newswire (US) • 07/11/2024 12:00:00 PM
- INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer • PR Newswire (US) • 07/02/2024 08:05:00 PM
- INOVIO Reports Inducement Grant Under Inducement Plan • PR Newswire (US) • 07/01/2024 08:00:00 PM
- INOVIO Added to Russell 2000® Index Effective July 1, 2024 • PR Newswire (US) • 07/01/2024 12:00:00 PM
- INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc. • PR Newswire (US) • 06/04/2024 12:00:00 PM
- INOVIO Reports Inducement Grants Under Inducement Plan • PR Newswire (US) • 05/31/2024 08:48:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 08:01:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:51:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:51:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:51:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:51:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:50:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:50:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:49:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 09:13:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 09:12:10 PM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM